A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma, Published online: 13 February 2018; doi:10.1038/bjc.2017.495
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinomahttp://ift.tt/2H9ZYk1
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου